AstraZeneca PLC (OTC Pink - Current Information:AZNCF)

106.60
Delayed Data
As of Jul 10
 -0.20 / -0.19%
Today’s Change
75.15
Today|||52-Week Range
115.57
+5.54%
Year-to-Date
Moderna and Other Coronavirus Vaccine Developers to Testify in Congress July 21
11:20am / MotleyFool.com - Paid Partner Content
Novavax's Vaccine Just Scored $1.6 Billion From Operation Warp Speed. Here's What It Means for Investors.
Jul 08 / MotleyFool.com - Paid Partner Content
Is It Too Late to Buy Novavax Stock?
Jul 10 / MotleyFool.com - Paid Partner Content
3 Reasons You Shouldn't Get Your Hopes Too High About COVID-19 Vaccines
Jul 08 / MotleyFool.com - Paid Partner Content
4 Reasons Investors Are Betting Against Moderna
Jul 09 / MotleyFool.com - Paid Partner Content
Is There a Coronavirus Vaccine Yet?
Jul 08 / MotleyFool.com - Paid Partner Content
Is Vaxart Stock a Buy?
Jul 09 / MotleyFool.com - Paid Partner Content
Moderna’s COVID-19 Trial Delayed: Should Investors Worry?
Jul 07 / MotleyFool.com - Paid Partner Content
In the Race to a Coronavirus Vaccine, Buy Moderna Stock or Inovio Stock?
Jul 09 / MotleyFool.com - Paid Partner Content
CanSino's COVID-19 Vaccine Was Just Approved for Limited Use in China. Here's What Investors Should Know.
Jul 07 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close106.80
Today’s open110.25
Day’s range106.60 - 110.25
Volume3,023
Average volume (3 months)6,362
Market cap$140.3B
Data as of 07/10/2020

Growth & Valuation

Earnings growth (last year)-39.67%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+10.38%
P/E ratio--
Price/Sales5.38
Price/Book10.83

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$24.4B
Annual profit (last year)$1.3B
Net profit margin5.47%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Cambridge, Cambridgeshire

Forecasts

Chart unavailable